Go Pro
→ Here’s Why Trump Won’t End The Iran War (From Banyan Hill Publishing) (Ad)tc pixel
LON:DXRX

Diaceutics Final Earnings Report

Diaceutics logo
GBX 152 +7.00 (+4.83%)
As of 10:52 AM Eastern
ProfileEarnings HistoryForecast

Diaceutics EPS Results

Actual EPS
-GBX 2.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Diaceutics Announcement Details

Quarter
Final
Date
5/13/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Diaceutics Earnings Headlines

Diaceutics boosts employee share incentives and updates total voting rights
August 4 at 9:10 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-boosts-employee-share-incentives-and-updates-total-voting-rights?utm_source=marketbeat.com&utm_medium=referral
Canaccord Genuity Group Reiterates "Buy" Rating for Diaceutics (LON:DXRX)
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931268
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this spring, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.tc pixel
August 6 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Diaceutics Issues Shares Under Employee Incentive Schemes in Latest Block Listing Update
April 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-shares-under-employee-incentive-schemes-in-latest-block-listing-update?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Executes Routine Management Share Purchases Under Incentive Plan With No Change to Share Capital
April 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-executes-routine-management-share-purchases-under-incentive-plan-with-no-change-to-share-capital?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Issues New Shares to Trust as PDMRs Participate in Incentive Plan
February 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-new-shares-to-trust-as-pdmrs-participate-in-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile
Earnings Tools